Royal London Asset Management Ltd. Has $18.53 Million Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Royal London Asset Management Ltd. decreased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 0.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 31,179 shares of the biotechnology company’s stock after selling 179 shares during the quarter. Royal London Asset Management Ltd.’s holdings in Axon Enterprise were worth $18,530,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of AXON. Groupama Asset Managment acquired a new stake in shares of Axon Enterprise during the 3rd quarter valued at $200,000. Massachusetts Financial Services Co. MA acquired a new stake in shares of Axon Enterprise during the 3rd quarter valued at $120,553,000. Proficio Capital Partners LLC acquired a new position in Axon Enterprise during the 4th quarter worth about $78,414,000. Westfield Capital Management Co. LP lifted its holdings in Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after buying an additional 127,769 shares during the period. Finally, Assenagon Asset Management S.A. lifted its holdings in Axon Enterprise by 328.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock worth $86,354,000 after buying an additional 111,405 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on the company. The Goldman Sachs Group lifted their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. Needham & Company LLC reaffirmed a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a report on Wednesday, February 26th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Finally, JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. One analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus price target of $604.67.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $560.00 on Friday. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99. The firm has a market capitalization of $42.91 billion, a price-to-earnings ratio of 144.70, a PEG ratio of 5.17 and a beta of 1.12. The business has a 50-day simple moving average of $591.90 and a 200 day simple moving average of $540.96. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now owns 1,627 shares of the company’s stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,792 shares of company stock worth $1,087,843. Insiders own 5.70% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.